Tolazoline
From Wikipedia, the free encyclopedia
 |
|
|
Tolazoline
|
|
| Systematic (IUPAC) name | |
| 2-benzyl-4,5-dihydro-1H-imidazole | |
| Identifiers | |
| CAS number | 59-98-3 |
| ATC code | C04AB02 M02AX02 |
| PubChem | 5504 |
| DrugBank | APRD00170 |
| Chemical data | |
| Formula | C10H12N2 |
| Mol. weight | 160.216 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tolazoline is a competitive α-adrenergic receptor antagonist. It is a vasodilator that is used to treat spasms of peripheral blood vessels (as in acrocyanosis).
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
